- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Symbiotec Pharmalab Ltd (SYMI)
Symbiotec Pharmalab Ltd stock price live, this page displays NSE SYMI stock exchange data. View the SYMI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Symbiotec Pharmalab Ltd real time stock price chart below.
What Is the Symbiotec Pharmalab Ltd Stock Price Today?
The Symbiotec Pharmalab Ltd stock price today is 1,115.00.
What Is the Stock Symbol for Symbiotec Pharmalab Ltd?
The stock symbol for Symbiotec Pharmalab Ltd is "SYMI."
What Stock Exchange Does Symbiotec Pharmalab Ltd Trade On?
Symbiotec Pharmalab Ltd is listed and trades on the NSE stock exchange.
Is Symbiotec Pharmalab Ltd a Good Stock to Buy?
Determining whether Symbiotec Pharmalab Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYMI quote. (ISIN: INE899I01028)
What Is the Symbiotec Pharmalab Ltd Stock Price Today?
The Symbiotec Pharmalab Ltd stock price today is 1,115.00.
What Is the Stock Symbol for Symbiotec Pharmalab Ltd?
The stock symbol for Symbiotec Pharmalab Ltd is "SYMI."
What Stock Exchange Does Symbiotec Pharmalab Ltd Trade On?
Symbiotec Pharmalab Ltd is listed and trades on the NSE stock exchange.
Is Symbiotec Pharmalab Ltd a Good Stock to Buy?
Determining whether Symbiotec Pharmalab Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SYMI quote. (ISIN: INE899I01028)
1,115.00
+27.50(+2.53%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,067.60
1,116.90
52 wk Range
934.20
1,246.00
SYMBIOTEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,067.601,116.90
52 wk Range
934.201,246.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SYMBIOTEC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1,540.00
Upside
+38.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,540.00
(+38.12% Upside)
Earnings
Latest Release
Sep 21, 2026
EPS / Forecast
2.24 / --
Revenue / Forecast
2.18B / --
Compare SYMBIOTEC to Peers and Sector
Metrics to compare | SYMBIOTEC | Peers Peers - average of corresponding metrics from companies closely matching SYMBIOTEC: CONCORDBIO, LAURUSLABS, DIVISLAB, COHANCE, 600488 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYMBIOTECPeersSector |
|---|---|---|---|---|
P/E Ratio | 74.3x | 34.9x | −0.3x | |
PEG Ratio | - | 0.88 | 0.00 | |
Price/Book | 6.1x | 4.0x | 2.6x | |
Price / LTM Sales | 7.9x | 3.7x | 3.0x | |
Upside (Analyst Target) | 41.6% | 13.5% | 59.8% | |
Fair Value Upside | Unlock | 3.7% | 7.1% | Unlock |
Symbiotec Pharma Lab Pvt. Ltd. develops, manufactures, and markets active pharmaceutical ingredients (APIs), with a primary focus on cortico-steroids and steroid-hormone APIs in both sterile and non-sterile forms. The company synthesizes progestin, estrone, testosterone, their derivatives, and anabolic steroids, supplying these in commercial volumes globally. It offers APIs and intermediate pharmaceutical products for therapeutic areas such as gastrointestinal ailments, cardiovascular disease, pain management, paediatrics, anti-infective, and dermatology. The company provides contract manufacturing (CMO) and contract development and manufacturing (CDMO) services, particularly for fermentation-based APIs, and operates large-scale manufacturing facilities with dedicated research and development and quality control laboratories. Its product portfolio includes APIs outside the cortico-steroids and hormone categories, with several products under development. The company serves clients in the pharmaceutical industry, including organizations involved in pharmaceutical manufacturing, contract manufacturing, and research and development, as well as global pharmaceutical companies. The company was founded in 1995 and is based in Indore, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Symbiotec Pharmalab (SYMBIOTEC) Stock Price Today?
The Symbiotec Pharmalab stock price today is 1,115.00 INR.
What Stock Exchange Does Symbiotec Pharmalab Trade On?
Symbiotec Pharmalab is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Symbiotec Pharmalab?
The stock symbol for Symbiotec Pharmalab is "SYMBIOTEC."
What Is the Symbiotec Pharmalab Market Cap?
As of today, Symbiotec Pharmalab market cap is 69.88B INR.
From a Technical Analysis Perspective, Is SYMBIOTEC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Symbiotec Pharmalab Stock Split?
Symbiotec Pharmalab has split 0 times.
How Many Employees Does Symbiotec Pharmalab Have?
Symbiotec Pharmalab has 1915 employees.
What is the current trading status of Symbiotec Pharmalab (SYMBIOTEC)?
As of Oct 12, 2026, Symbiotec Pharmalab (SYMBIOTEC) is trading at a price of 1,115.00 INR, with a previous close of 1,087.50 INR. The stock has fluctuated within a day range of 1,067.60 INR to 1,116.90 INR, while its 52-week range spans from 934.20 INR to 1,246.00 INR.
What Is Symbiotec Pharmalab (SYMBIOTEC) Price Target According to Analysts?
The average 12-month price target for Symbiotec Pharmalab is 1,540.00 INR, with a high estimate of 1540 INR and a low estimate of 1540 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +38.12% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.